Gene: ABCB1
Official Full Name: ATP binding cassette subfamily B member 1provided by HGNC
Gene Summary: The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02667 | ABCB1 Knockout cell line (HeLa) | Human | ABCB1 | 1:3~1:6 | Negative | Online Inquiry |
KO02668 | ABCB1 Knockout cell line (HCT 116) | Human | ABCB1 | 1:2~1:4 | Negative | Online Inquiry |
KO02669 | ABCB1 Knockout cell line (HEK293) | Human | ABCB1 | 1:3~1:6 | Negative | Online Inquiry |
ABCB1 Gene Knockout Cell Lines are a powerful tool in molecular biology, specifically designed to study the role of the ABCB1 gene, also known as P-glycoprotein. This gene encodes a membrane transporter protein that plays a crucial role in the efflux of various substrates across cellular membranes, influencing drug absorption and pharmacokinetics in both normal physiology and disease states. These knockout cell lines enable researchers to effectively eliminate the expression of the ABCB1 gene, allowing for detailed analysis of its function and the resulting cellular effects.
The primary function of these cell lines lies in their ability to mimic physiological conditions where ABCB1 is no longer expressed. Through the mechanism of CRISPR-Cas9 gene editing technology, the knockout cells provide a controlled environment to investigate the impacts on drug resistance, metabolic pathways, and intracellular drug accumulation. This is particularly significant in cancer research, where ABCB1 is often implicated in multidrug resistance, hindering effective treatment strategies.
The scientific importance of ABCB1 Gene Knockout Cell Lines extends into numerous applications, including drug discovery, pharmacological studies, and toxicology assessments. They facilitate the examination of new therapeutic agents and allow for the identification of potential drug interactions or adverse effects without the confounding variable of ABCB1 activity. Additionally, these cell lines offer a reproducible model for validating research findings across various preclinical studies.
Compared to traditional approaches, such as RNA interference or the use of chemical inhibitors, ABCB1 Gene Knockout Cell Lines provide a permanent and stable solution for the study of gene function. Researchers benefit from consistent expression profiles, reducing variability and increasing the reliability of experimental outcomes. Furthermore, the knockout model permits the assessment of cellular responses to a wider range of substrates, enhancing the robustness of data obtained.
For researchers and clinicians focused on drug development or toxicological studies, the ABCB1 Gene Knockout Cell Lines represent an indispensable resource, allowing for in-depth exploration of drug-related questions. As a product offering from our company, we pride ourselves on delivering engineered cell lines that meet the highest standards of quality and scientific validity. Our expertise in molecular biology ensures that customers receive robust products tailored to advance their research initiatives effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.